Biohaven (NYSE:BHVN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Biohaven (BHVN) operate in?

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.

Open	$40.21
Close	-
Volume / Avg.	249.80K / 958.39K
Day Range	$38.25 - $40.82
52 Wk Range	26.80 - 62.21
Market Cap	$3.84B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	45
Short Interest	10.48%
Days to Cover	11.03

Recent News

Financial Crime Weekly: Pfizer Pays Nearly $60 Million To Resolve False Claims Allegations, SEC Creates Crypto Task Force

The DOJ announces Pfizer agreed to pay nearly $60 million to resolve false claims allegations. The SEC creates a task force dedicated to the development of a clear and comprehensive regulatory framework for crypto assets.

Erica Kollmann

What's Going On With Merus Stock Monday?

Merus announced a research collaboration and license agreement with Biohaven.

Dylan Berman

Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval

Biohaven's BHV-1300 shows >60% IgG reduction in early trials with promising safety data, advancing its MoDE platform and regulatory milestones.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Dec 24

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$40.21
Close	-
Volume / Avg.	249.80K / 958.39K
Day Range	$38.25 - $40.82
52 Wk Range	26.80 - 62.21
Market Cap	$3.84B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	45
Short Interest	10.48%
Days to Cover	11.03

About Biohaven Ltd

Sector

Health Care

Industry

Biotechnology

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, an...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Biohaven (BHVN) stock?

You can purchase shares of Biohaven (NYSE:BHVN) through any online brokerage.

View our list of the best stock brokerages

Who are Biohaven (BHVN) competitors?

Other companies in Biohaven’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).

What is the forecast, or price target, for Biohaven (BHVN) stock?

Biohaven has a consensus price target of $73.56.

What is the current price for Biohaven (BHVN)?

The stock price for Biohaven (NYSE: BHVN) is $38 last updated February 21, 2025 at 1:27 PM EST.

Does Biohaven (BHVN) pay a dividend?

There are no upcoming dividends for Biohaven.

When is Biohaven (NYSE:BHVN) reporting earnings?

Biohaven’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Biohaven (BHVN) going to split?

There is no upcoming split for Biohaven.

What sector and industry does Biohaven (BHVN) operate in?

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Comments

Biohaven

Biohaven (BHVN) Forecast